Baird Medical Investment Holdings (BDMD) Change in Accured Expenses (2024 - 2025)

Baird Medical Investment Holdings (BDMD) recorded quarterly Change in Accured Expenses of $2.6 million in Q2 2025, up 4.17% quarter-over-quarter from $2.5 million in Q4 2024.

Baird Medical Investment Holdings (BDMD) Change in Accured Expenses (2024 - 2025) Analysis & Trends

Baird Medical Investment Holdings' Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $2.6 million for Q2 2025.

  • In Q2 2025, Change in Accured Expenses changed N/A year-over-year to $2.6 million; the TTM figure through Jun 2025 stood at $2.6 million (changed N/A YoY), while the FY2025 annual figure was -$450913.0, down 117.91% from the prior year.
  • Change in Accured Expenses was $2.6 million for Q2 2025 at Baird Medical Investment Holdings, up from $2.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.6 million in Q2 2025 to a low of $2.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -654.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 703.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -347.10 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -250.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 21.07 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 145.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 74.30 Mn
10 Baird Medical Investment Holdings - - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 2.62 Mn
Jun 30, 2025 2.62 Mn
Dec 31, 2024 2.52 Mn
Dec 31, 2024 2.52 Mn